ABBV vs DELL: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Dell Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-21.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Dell Technologies Inc. · Technology
$569.00
-32.5% upside to fair value
Low Conviction
Grade C
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
DELL |
| Current Price |
$261.70 |
$569.00 |
| Fair Value Estimate |
$259.04 |
$383.93 |
| Upside to Fair Value |
-1.0%
|
-32.5%
|
| Market Cap |
$462.4B |
$378.0B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
21.8x
|
| Price / Sales |
7.2x
|
2.5x
|
| Price / FCF |
23.6x
|
42.9x
|
| Revenue Growth YoY |
+10.2%
|
+57.7%
|
| Gross Margin |
71.5%
|
19.8%
|
| Operating Margin |
29.3%
|
9.6%
|
| Return on Equity |
-136.5%
|
-574.6%
|
| Dividend Yield |
2.61% |
0.41% |
| FCF Yield |
4.25%
|
2.33%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Dell Technologies is a $378 billion market-cap computer hardware vendor spanning Infrastructure Solutions Group (servers, storage, networking), Client Solutions Group (PCs, displays, peripherals), and a VMware-related software franchise, led by founder-CEO Michael Dell. The business is fundamentally low-quality on the numbers: TTM gross margin is 19.8%, operating margin 9.6%, and net margin 7.5%,…
Accumulation Zones
| Metric |
ABBV |
DELL |
| Zone Low |
$194.28 |
$287.95 |
| Zone High |
$220.18 |
$326.34 |
| In Buy Zone? |
No
|
No
|